Wei Zhong
ORCID: 0000-0003-2917-4832Also affiliated with Guangzhou Women and Children Medical Center, Ondine Biopharma (United States), Mayo Clinic in Arizona, Guangzhou Medical University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 4 papers. Top paper: “High FLT3 Levels May Predict Sorafenib Benefit in Hepatocellular Carcinoma”.
Shi-Chao Li, Li Xu, Wei Zhong, Zhen-Guang Wang, Chu-zhi Pan +9 more
Ann C. Mladek, Sneha Rathi, Sonia Jain, Rachael A. Vaubel, Lateef A Odukoya +17 more
Sneha Rathi, Margaret A. Connors, Michael P. Grams, Rachael A. Vaubel, Katrina K. Bakken +13 more
Dhruv Sud, Mei Wu, Karl A. Merrick, Sofia D. Merajver, David G. Beer +2 more